Safe use of the drug in the treatment of adolescent rheumatoid joint inflammation has not been developed.


Use of this medication is contraindicated (1) in the visibility of aesthetic or retinal industry changes attributable to any sort of 4-aminoquinoline substance, (2) in patients with recognized irritation to 4-aminoquinoline compounds, and also (3) for lasting treatment in youngsters.

More Details